The project is the continuation of the CTI project 5844.2 FHS. In addition to the Laves Arzneimittel GmbH and the Hochschule WÃ¤denswil, the Bern University of applied sciences, the Inselspital Bern, as well as five more SMEs are involved. The aim of the project is the derivation of model transfer criteria for the cultivation of HEK cells and E. coli in wave systems. The work focuses plc but on the concept of a disposable manufacturing facility for the production of immune modulators on the base of the wave of 200.
